Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Takeda Pharmaceutical Company Limited TKPHF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Takeda Pharmaceutical Company Limited (TKPHF) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.

TKPHF Analyst Ratings

Buy
5
Ratings
4 Buy
1 Hold
Based on 5 analysts giving stock ratings to Takeda Pharmaceutical Company Limited in the past 3 months
Rating breakdown
Buy
4 80%
Hold
1 20%
80%
Buy
4 analysts
20%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

CHGCY
CHGCY
Chugai Pharmaceutical Co., Ltd.
$27.20
+0.76%
 MKKGY
MKKGY
MERCK Kommanditgesellschaft auf Aktien
$27.62
+0.77%
 DSKYF
DSKYF
Daiichi Sankyo Company, Limited
$18.20
+4.54%
 ALPMF
ALPMF
Astellas Pharma Inc.
$15.75
-4.72%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message